Day One Biopharmaceuticals (DAWN) PT Lowered to $54 at Goldman Sachs

August 8, 2023 5:59 AM EDT Send to a Friend

Goldman Sachs analyst Andrea Tan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Day One Biopharmaceuticals (DAWN) PT Lowered to $54 at Goldman Sachs

Member Login

Free News Feed